Skip to main content

Table 2 Differentially expressed genes in psoriatic lesions compared to healthy controls (LP-C)

From: Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN

Symbol

logFC

logCPM

PValue

FDR

Entrez Gene Name

OAS2

4.43

7.16

9.26E-70

2.14E-65

2'-5'-oligoadenylate synthetase 2

PLA2G4E

2.55

7.60

2.74E-68

3.16E-64

Phospholipase A2, group IVE

KLK9

5.20

4.01

2.20E-67

1.69E-63

Kallikrein-related peptidase 9

S100A12

9.00

4.41

1.25E-65

7.20E-62

S100 calcium binding protein A12

LCE3E

6.99

4.45

6.02E-65

2.78E-61

Late cornified envelope 3E

TGM1

3.42

6.51

4.94E-61

1.90E-57

Transglutaminase 1

OAS3

2.99

7.25

1.01E-59

3.33E-56

2'-5'-oligoadenylate synthetase 3

PARP9

2.20

7.11

2.80E-59

8.08E-56

Poly (ADP-ribose) polymerase, 9

CRABP2

2.49

5.65

1.99E-57

5.10E-54

Cellular retinoic acid binding protein 2

PLA2G4D

4.33

6.10

3.03E-56

7.01E-53

Phospholipase A2, group IVD

IL1F9

5.64

6.61

2.26E-55

4.74E-52

Interleukin 36, gamma

ALOX12B

3.01

7.30

7.12E-55

1.37E-51

Arachidonate 12-lipoxygenase

SAMD9

3.01

6.23

8.59E-55

1.53E-51

Sterile alpha motif domain

IL1F5

3.59

7.91

1.14E-53

1.87E-50

Interleukin 36 receptor antagonist

C10orf99

6.22

5.44

3.20E-52

4.93E-49

Chrom 10 open reading frame 99

DEFB4A

10.43

6.59

6.30E-52

9.09E-49

Defensin. beta 4A

AKR1B10

6.22

4.39

4.02E-51

5.46E-48

Aldo-keto reductase family 1

PAPL

4.01

4.60

1.56E-50

2.01E-47

Iron/zinc purple acid protein

GLTP

2.01

7.42

5.00E-50

6.08E-47

Glycolipid transfer protein

KDM6B

−1.36

11.51

1.48E-49

1.71E-46

Lysine (K)-specific demethylase 6B

KYNU

4.49

4.72

2.54E-48

2.79E-45

Kynureninase

RRM2

2.68

5.47

3.29E-48

3.46E-45

Ribonucleotide reductase M2

ZC3H12A

3.06

4.88

2.30E-47

2.31E-44

Zinc finger CCCH-type cont 12A

SDR9C7

2.70

5.00

6.01E-47

5.79E-44

Short chain dehydrogenase/reductase

HPSE

3.47

4.17

1.31E-46

1.21E-43

Heparanase

APOL6

2.23

6.52

1.91E-46

1.69E-43

Apolipoprotein L, 6

NIPAL4

1.39

9.13

6.90E-46

5.90E-43

NIPA-like domain containing 4

DMD

−1.81

7.46

9.69E-46

7.99E-43

Dystrophin

S100A7A

10.02

10.30

2.84E-45

2.26E-42

S100 calcium binding protein A7A

  1. LogFC is fold changes differences in log2 scale and it describes how many times gene expression differs between groups. Positive values indicate up-regulation in psoriasis. LogCPM (log2 counts-per-million) is average gene expression signal in all samples. FDR is genome-wide corrected P-value.